beta amyloid

Galimedix's oral Alzheimer's candidate clears ph. 1 safety test

The small molecule caused no serious adverse events and successfully crossed the blood-brain barrier in a trial with more than 100 healthy volunteers.

Darren Incorvaia Sep 12, 2025 11:11am

Denali Alzheimer's antibody clears plaques without ARIA in mice

Aug 7, 2025 2:00pm

Eisai rocked by 2nd death ahead of Alzheimer’s data reveal

Nov 28, 2022 10:53am

In 'major surprise,' Eisai, Biogen post pivotal Alzheimer's win

Sep 28, 2022 4:30am

Scientists find druggable path that may help treat Alzheimer's

Aug 29, 2022 7:26pm

FDA clears its first early amyloid test for Alzheimer’s disease

May 10, 2022 11:42am